Bruker vs Henry Schein
Bruker (BRKR), health care, and Henry Schein (HSIC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Bruker is worth $9.4B on the stock market and Henry Schein $9.2B: Bruker is valued at 2% more. Bruker's operating margin in its latest fiscal year was 1.98% and Henry Schein's 4.95%. Over the past year Bruker's share price has moved +42.1% and Henry Schein's +19.3%.
Key facts
- Bruker market value
- $9.4B
- Henry Schein market value
- $9.2B
- Henry Schein P/E
- 22.7
- Bruker revenue
- $3.4BFY to 2025-12-31
- Henry Schein revenue
- $13.2BFY to 2025-12-27
- Superinvestors holding both
- 0
Market values as of .
| Measure | Bruker | Henry Schein |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-27 |
| Size | ||
| Market cap | $9.4Bhigher | $9.2Blower |
| Revenue | $3.4Blower | $13.2Bhigher |
| Earnings | -$8.6Mlower | $398Mhigher |
| Employees | 11,085lower | 25,000higher |
| Total assets | $6.2Blower | $11.2Bhigher |
| Valuation | ||
| P/E | — | 22.7 |
| P/S | 2.7higher | 0.7lower |
| P/B | 4.1higher | 2.9lower |
| Dividend yield | 0.08%higher | 0.00%lower |
| Profitability | ||
| Operating margin | 1.98%lower | 4.95%higher |
| Balance sheet | ||
| Net assets | $2.5Blower | $3.2Bhigher |
| Total liabilities | $3.7Blower | $6.4Bhigher |
| Total debt | $1.9Blower | $3.1Bhigher |
| Cash on hand | $298.8Mhigher | $156Mlower |
| Price change | ||
| Today | +1.22%higher | -2.38%lower |
| 1 year | +42.1%higher | +19.3%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Bruker only (4)
Henry Schein only (7)
- Andrew Wellington1.7%
- David Einhorn1.5%
- Pat English1.1%
- Mario Gabelli0.3%
- Richard Pzena0.2%
- Ken Griffin0.1%
- Mason Hawkins0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns BRKR · Who owns HSIC
More on Bruker
Further comparisons
Bruker against its closest peers
Henry Schein against its closest peers
Learn
Questions and answers
Which is bigger, Bruker or Henry Schein?
By market value, Bruker is the larger: $9.4B against $9.2B for Henry Schein. By revenue in its latest fiscal year, Henry Schein is the larger: $13.2B against $3.4B for Bruker.
Which has the higher operating margin?
Henry Schein: 4.95%, against 1.98% for Bruker. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Bruker: 0.08%, against 0.00% for Henry Schein. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Henry Schein: $3.1B, against $1.9B for Bruker. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Bruker and Henry Schein?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Bruker and 7 hold Henry Schein.
Cite this page
Funkfolio, “Bruker vs Henry Schein”, data as of 18 November 2026. https://funkfolio.com/compare/brkr-vs-hsic
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.